Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...

KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

Please provide your email address to receive an email when new articles are posted on . Higher fecal hemoglobin concentrations at baseline suggest a shorter repeat screening interval. Screening ...

Over a 20-year period, colorectal cancer screening rates approximately doubled and mortality declined across all racial groups following systematic outreach. Colorectal cancer (CRC) screening rates ...

A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...

ACG posed several key questions and developed practical recommendations for practice providers. The recommendations were crafted through a focused literature search and supplemented by existing ...

Blood-based screening for colorectal cancer (CRC) should only be used with patients who are not completing other endorsed screening options, according to a study. This study aimed to use a simulation ...

A mailed fecal immunochemical test (FIT) outreach followed by patient navigation for those with a positive test increased colorectal cancer (CRC) screening participation at 6 months compared with ...

Older adults with limited life expectancy are just as likely to undergo colorectal cancer (CRC) screening as those with longer life expectancy, a new study shows. Researchers used national survey data ...

Please provide your email address to receive an email when new articles are posted on . Data showed that colorectal cancer screening delays of 1 to 2 years because of the COVID-19 pandemic had minimal ...